Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine-infused fibrin sealant for post-tonsillectomy pain and hemorrhage
NCT02343263Phase 2Terminated
- Sponsor
- Indiana University School of Medicine
- Start
- Mar 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain and postoperative hemorrhage, sponsored by Indiana University School of Medicine. Started Mar 2015; status: terminated.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative painpostoperative hemorrhage
Beyond the preview
Go deeper on NCT02343263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343263.